EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.5.1.23 | (1R,2R)-2-(N-tetradecanoylamino)-1-(4-nitrophenyl)-1,3-propanediol | the efficacy of (1R,2R)-2-(N-tetradecanoylamino)-1-(4-nitrophenyl)-1,3-propanediol in vitro as well as in intact cells can be enhanced by suitable modification of functional groups; the efficacy of the inhibitor in vitro as well as in intact cells can be enhanced by suitable modification of functional groups | Homo sapiens | |
3.5.1.23 | (1S,2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol | - |
Homo sapiens | |
3.5.1.23 | 12-amino-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]dodecanamide | - |
Homo sapiens | |
3.5.1.23 | additional information | structural modification of the known ceramidase inhibitors (1R,2R)-2-(N-tetradecanoylamino)-1-(4-nitrophenyl)-1,3-propanediol and N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]-12-(dimethylamino)dodecanamide generates more potent ceramidase inhibitors that are active in intact cells and not only elevates the cellular ceramide levels, but also enhances cell death | Homo sapiens | |
3.5.1.23 | N-(2-hydroxy-2-phenylethyl)tetradecanamide | - |
Homo sapiens | |
3.5.1.23 | N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]-12-(dimethylamino)dodecanamide | - |
Homo sapiens | |
3.5.1.23 | N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]tridecan-1-aminium chloride | - |
Homo sapiens | |
3.5.1.23 | N-[(1R,2R)-1,3-dihydroxy-1-phenylpropan-2-yl]tridecan-1-aminium chloride | - |
Homo sapiens | |
3.5.1.23 | N-[(1R,2S)-1-hydroxy-1-phenylpropan-2-yl]-12-(1-methylhydrazinyl)dodecanamide | - |
Homo sapiens | |
3.5.1.23 | N-[(2R)-2-hydroxy-2-(pyridin-3-yl)ethyl]-12-(1-methylhydrazinyl)dodecanamide | - |
Homo sapiens | |
3.5.1.23 | N-[(2R)-2-hydroxy-2-(pyridin-4-yl)ethyl]-12-(1-methylhydrazinyl)dodecanamide | - |
Homo sapiens | |
3.5.1.23 | N-[2-hydroxy-2-(pyridin-3-yl)ethyl]-12-(1-methylhydrazinyl)dodecanamide | - |
Homo sapiens | |
3.5.1.23 | N-[2-hydroxy-2-(pyridin-3-yl)ethyl]tetradecanamide | - |
Homo sapiens | |
3.5.1.23 | N-[2-hydroxy-2-(pyridin-4-yl)ethyl]tetradecanamide | - |
Homo sapiens | |
3.5.1.23 | oleoylethanolamide | i.e. N-oleylethanolamine; i.e. N-oleylethanolamine | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.5.1.23 | Homo sapiens | Q13510 | - |
- |
3.5.1.23 | Homo sapiens | Q9NR71 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.5.1.23 | breast cancer cell | - |
Homo sapiens | - |
3.5.1.23 | MDA-MB-231 cell | - |
Homo sapiens | - |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.5.1.23 | aCDase | - |
Homo sapiens |
3.5.1.23 | acid ceramidase | - |
Homo sapiens |
3.5.1.23 | ASAH1 | - |
Homo sapiens |
3.5.1.23 | ASAH2 | - |
Homo sapiens |
3.5.1.23 | N-acylsphingosine amidohydrolase 2 | - |
Homo sapiens |
3.5.1.23 | nCDase | - |
Homo sapiens |
3.5.1.23 | neutral ceramidase | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
3.5.1.23 | 37 | - |
assay at | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
3.5.1.23 | 4.5 | - |
assay at | Homo sapiens |
3.5.1.23 | 7 | - |
assay at | Homo sapiens |